Rhinozyn®

Probiotic Solution
for Allergic Rhinitis

child in a blossom field

Key marketing aspects

  • targeting the most frequent allergic disease
  • unique combination of patented probiotic strains selected for the treatment of allergic rhinitis and for restoring the allergic immune system
  • plus vitamin D – health claim related to the normal function of the immune system and inflammatory response
  • reducing both eye and nasal symptoms in perennial rhinitis
  • improving quality of life during allergy season (even in subjects using pharmacotherapy)
  • natural alternative to pharmacotherapy or add-on to antihistaminic
  • clinically tested in children & adults
  • most efficient probiotic solution available for the treatment of allergic rhinitis
  • pharmacy exclusive

Facts

  • 3 randomized clinical trials published reporting improvements in a total of 305 subjects treated
  • significant reduction of clinical symptoms of perennial rhinitis
  • compelling improvement of quality of life (RQLQ) in seasonal rhinitis
  • stimulating the Th1 immune response and reducing IgE synthesis
  • vitamin D modulates the immune response and is associated with aeroallergen sensitization and allergic rhinitis
  • highest clinical efficacy amongst probiotic treatments for allergic rhinitis

Conclusion

  • significant evidence of beneficial clinical effects of Rhinozyn® in the treatment of allergic rhinitis
  • adjunctive therapy with Rhinozyn® can be recommended for the treatment of allergic rhinitis
  • meta analysis proves Rhinozyn® to be the leading probiotic treatment for allergic rhinitis
How to use
  • once a day
  • stand-alone or add-on to pharmacotherapy

 

capsule packaging Rhinozyn®

Rhinozyn® is a registered trademark of Bluestone Pharma GmbH